No Data
No Data
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Express News | Teva : BofA Global Research Raises Price Objective to $26 From $25
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
Novo Nordisk Seeks to Block Compounded Victoza
Insider Trades: Walmart, Teva Among Notable Names This Week
Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath
No Data